Pfizer Asks F.D.A. to Authorize Its Covid-19 Vaccine for Children 5 to 11

Pfizer files for FDA approval on coronavirus vaccine for ages 5-11

Pfizer filed an application with the Food and Drug Administration on Thursday seeking emergency use authorization for its coronavirus vaccine that is approved for distribution among children age 5-11.

Vermont docs hopeful after Pfizer asks to authorize shots for ages 5 to 11

(WFFF) — It will be at least a few more weeks until the FDA decides whether to authorize the Pfizer vaccine for the country's youngest age band, but some Vermont parents, children, and pediatricians are hopeful. Pfizer asks for emergency approval of vaccine for kids 5 to 11 Dr. William Raszka is the Director of the Pediatric Infectious Disease Service at Vermont Children's Hospital. He says the nation is taking another important step in the …

Studies Confirm Pfizer Vaccine Immunity Wanes at 2 Months, as Pharma Giant Seeks FDA Approval for Kids 5 to 11

A study from Israel covering 4,800 healthcare workers showed antibody levels waned rapidly after two doses of Pfizer’s COVID vaccine. Meanwhile, Pfizer today officially asked the U.S. Food and Drug Administration to authorize its vaccine for children 5 to 11 years old.

Local health agencies start planning for Pfizer vaccine distribution if approved for kids ages 5-11

Local health agencies are preparing for Pfizer’s COVID vaccine to be approved for kids ages 5 to 11.  The pharmaceutical company sent its request in to the FDA Thursday.  …

Local health care providers prepare for Pfizer vaccine distribution if approved for kids ages 5-11

Local health agencies are preparing for Pfizer's COVID vaccine to be approved for kids ages 5 to 11. The pharmaceutical company sent its request in to the FDA Thursday.  Pfizer asks for emergency approval of vaccine for kids 5 to 11 The FDA is scheduled to meet on October 26th, then it goes to the CDC, which could put potential approval sometime in November. That’s why the Indiana Department of Health and other agencies say they are already …

Pfizer seeks U.S. COVID-19 vaccine clearance for children age 5 to 11

The Food and Drug Administration has set a date of Oct. 26 for its panel of outside advisers to meet and discuss the application.